Literature DB >> 25189434

Microvascular dysfunction in the context of diabetic neuropathy.

Alin Stirban1.   

Abstract

Microvascular dysfunction in diabetes plays a crucial role in the development of diabetic complications. The skin, as one of the most accessible organs, serves as a model for the investigation of microvascular dysfunction. Several non-invasive, mostly laser-Doppler-based methods have been developed lately to assess microvascular function in the skin. Microvascular functional changes occur even in the prediabetic state and become more complex with overt diabetes, being exacerbated by the presence of peripheral and/or autonomic diabetic neuropathy. The present article aims at shedding light on the implication of endothelial and neurovascular dysfunction in microvascular changes in diabetes, highlighting the contribution of different forms of diabetic neuropathy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25189434     DOI: 10.1007/s11892-014-0541-x

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  83 in total

Review 1.  Defects in microvascular haemodynamics during prediabetes: contributor or epiphenomenon?

Authors:  N Wiernsperger
Journal:  Diabetologia       Date:  2000-11       Impact factor: 10.122

Review 2.  Painful diabetic neuropathy.

Authors:  S Tesfaye; P Kempler
Journal:  Diabetologia       Date:  2005-05       Impact factor: 10.122

3.  Quantitative objective assessment of peripheral nociceptive C fibre function.

Authors:  N Parkhouse; P M Le Quesne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-01       Impact factor: 10.154

4.  The influence of isolated small nerve fibre dysfunction on microvascular control in patients with diabetes mellitus.

Authors:  A Pfützner; T Forst; M Engelbach; T Margin; K Goitom; M Löbig; J Beyer; T Kunt
Journal:  Diabet Med       Date:  2001-06       Impact factor: 4.359

5.  The LDIflare: a novel test of C-fiber function demonstrates early neuropathy in type 2 diabetes.

Authors:  Singhan T M Krishnan; Gerry Rayman
Journal:  Diabetes Care       Date:  2004-12       Impact factor: 19.112

Review 6.  Microcirculation of the diabetic foot.

Authors:  T Dinh; A Veves
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

7.  Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus.

Authors:  Alin Stirban; Simona Nandrean; Christian Götting; Ronald Tamler; Alexandra Pop; Monica Negrean; Thomas Gawlowski; Bernd Stratmann; Diethelm Tschoepe
Journal:  Am J Clin Nutr       Date:  2010-01-13       Impact factor: 7.045

8.  Skin microcirculation in patients with type I diabetes with and without neuropathy after neurovascular stimulation.

Authors:  T Forst; A Pfützner; T Kunt; T Pohlmann; U Schenk; R Bauersachs; E Küstner; J Beyer
Journal:  Clin Sci (Lond)       Date:  1998-03       Impact factor: 6.124

9.  Microvascular response to tissue injury and capillary ultrastructure in the foot skin of type I diabetic patients.

Authors:  G Rayman; R A Malik; A K Sharma; J L Day
Journal:  Clin Sci (Lond)       Date:  1995-11       Impact factor: 6.124

10.  Patterns of diffusion through skin capillaries in patients with long-term diabetes.

Authors:  A Bollinger; J Frey; K Jäger; J Furrer; J Seglias; W Siegenthaler
Journal:  N Engl J Med       Date:  1982-11-18       Impact factor: 91.245

View more
  15 in total

1.  Angiopoietin-1/Tie2 signaling pathway contributes to the therapeutic effect of thymosin β4 on diabetic peripheral neuropathy.

Authors:  Lei Wang; Michael Chopp; Alexandra Szalad; XueRong Lu; Mei Lu; Talan Zhang; Zheng Gang Zhang
Journal:  Neurosci Res       Date:  2018-10-13       Impact factor: 3.304

2.  Differences in limb volume trajectories after breast cancer treatment.

Authors:  Betty Smoot; Bruce A Cooper; Yvette Conley; Kord Kober; Jon D Levine; Judy Mastick; Kimberly Topp; Christine Miaskowski
Journal:  J Cancer Surviv       Date:  2015-12-18       Impact factor: 4.442

Review 3.  Vasoregression: A Shared Vascular Pathology Underlying Macrovascular And Microvascular Pathologies?

Authors:  Akanksha Gupta; Sonika Bhatnagar
Journal:  OMICS       Date:  2015-12

4.  Influence of GSTM1, GSTT1, and GSTP1 Polymorphisms on Type 2 Diabetes Mellitus and Diabetic Sensorimotor Peripheral Neuropathy Risk.

Authors:  Adina Stoian; Claudia Bănescu; Rodica Ioana Bălaşa; Anca Moţăţăianu; Mircea Stoian; Valeriu G Moldovan; Septimiu Voidăzan; Minodora Dobreanu
Journal:  Dis Markers       Date:  2015-09-08       Impact factor: 3.434

Review 5.  Vascular Effects of Dietary Advanced Glycation End Products.

Authors:  Alin Stirban; Diethelm Tschöpe
Journal:  Int J Endocrinol       Date:  2015-05-18       Impact factor: 3.257

6.  Peripheral sensory neuropathy is associated with altered postocclusive reactive hyperemia in the diabetic foot.

Authors:  Alex L Barwick; John W Tessier; Xanne Janse de Jonge; James R Ivers; Vivienne H Chuter
Journal:  BMJ Open Diabetes Res Care       Date:  2016-07-07

Review 7.  The association between diabetes and dermal microvascular dysfunction non-invasively assessed by laser Doppler with local thermal hyperemia: a systematic review with meta-analysis.

Authors:  Dagmar Fuchs; Pepijn P Dupon; Laura A Schaap; Richard Draijer
Journal:  Cardiovasc Diabetol       Date:  2017-01-19       Impact factor: 9.951

Review 8.  A Synoptic Overview of Neurovascular Interactions in the Foot.

Authors:  Gayathri Balasubramanian; Prashanth Vas; Nachiappan Chockalingam; Roozbeh Naemi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-22       Impact factor: 5.555

Review 9.  Remote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulceration.

Authors:  J A Epps; N A Smart
Journal:  Cardiovasc Diabetol       Date:  2016-09-09       Impact factor: 9.951

10.  Parahippocampal gyrus expression of endothelial and insulin receptor signaling pathway genes is modulated by Alzheimer's disease and normalized by treatment with anti-diabetic agents.

Authors:  P Katsel; P Roussos; M S Beeri; M A Gama-Sosa; S Gandy; S Khan; V Haroutunian
Journal:  PLoS One       Date:  2018-11-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.